引用次数
引用: 71,419
H-指数: 126
I10-指数 : 483
出版物: 1,064
Anti-IL-5 therapy and the airway microbiome in asthma
Ashley Sullivan , Chris Ward , Deborah Casey , Deirdre Flynn
European Respiratory Journal 56
2020
The impact of anti-IgE treatment on the airway microbiome in asthma
Ashley Sullivan , Chris Ward , Deborah Casey , Deirdre Flynn
European Respiratory Journal 56
2020
Factors contributing to dyspnoea during bronchoconstriction and exercise in asthmatic subjects
P. M. O'byrne , R. M. Watson , E. Summers , K. J. Killian
European Respiratory Journal 6 ( 7) 1004 -1010
33
1993
The airway epithelium and asthma
P. M. O'byrne
Lung biology in health and disease 55 171 -186
2
1991
Structure of airway smooth muscle
P. M. O'byrne , I. Berezin , E. E. Daniel
Lung biology in health and disease 49 189 -208
3
1991
Role of neutrophils in the pathogenesis of airway hyperresponsiveness and asthma
P. M. O'byrne , E. E. Daniel
Lung biology in health and disease 49 441 -456
3
1991
EICOSANOIDS IN THE PATHOGENESIS OF EXERCISE- AND ALLERGEN-INDUCED ASTHMA
P. M. O'byrne
Lung biology in health and disease 114 259 -271
1998
Interaction between haemopoietic regulation and airway inflammation
P. M. O'byrne , G. M. Gauvreau , L. J. Wood
Clinical & Experimental Allergy 29 ( 2) 27 -32
46
1999
Prostaglandin E2 Modulates Cholinergic Neurotransmission in Canine Tracheal Muscle
E. H. Walters , P. M. O'byrne , J. A. Nadel
Clinical Science 66 ( 2)
1984
Beta2-agonists in asthma treatment
Paul M. O'Byrne , Romain Pauwels
Dekker
18
1997
Peripheral blood Th17 / Treg ratio increases in late asthmatic response
Paul M. O'Byrne , Ulrich Hoffmueller , Christopher R. Carlsten , Jian Ruan
European Respiratory Journal 42 3154
2013
Efficacy and safety of once-daily (OD) fluticasone furoate (FF) 50mcg over 24 weeks in adults and adolescents with persistent asthma
Eugene R. Bleecker , Paul M. O'Byrne , William W. Busse , Jan Lötvall
European Respiratory Journal 42 3397
2013
Effect of fluticasone furoate (FF)/vilanterol (VI) once daily (OD) on risk of severe exacerbations in asthma
Brett Haumann , Eugene R. Bleecker , Paul M. O'Byrne , William W. Busse
European Respiratory Journal 40 1788
1
2012
Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) compared with fluticasone propionate/salmeterol combination (FP/SAL) in adults and adolescents with persistent asthma
Eugene R. Bleecker , Paul M. O'Byrne , William W Busse , Jan Lötvall
European Respiratory Journal 40 1795
2
2012
Efficacy and safety of once-daily (OD) fluticasone furoate (FF) in adults and adolescents with moderate-to-severe persistent asthma
Eugene R. Bleecker , Paul M. O'Byrne , William W. Busse , Jan Lötvall
European Respiratory Journal 42 3398
1
2013
Exercise-induced Bronchoconstriction: Elucidating the Roles of Leukotrienes and Prostaglandins
Paul M. O'Byrne
Pharmacotherapy 17 ( 1)
14
1997
Safety and tolerability of the novel inhaled corticosteroid (ICS) fluticasone furoate (FF) in combination with the long-acting beta2 agonist (LABA) vilanterol (VI) administered once daily (OD) in patients with asthma
Ludovic Apoux , Eugene R. Bleecker , Paul M. O'Byrne , William W. Busse
European Respiratory Journal 40 2092
1
2012
Efficacy of budesonide/formoterol maintenance and reliever therapy in mild asthma
Malin Fagerås , Paul M. O'Byrne , Malcolm R. Sears , Helen K. Reddel
European Respiratory Journal 42 4125
2013
Are New Asthma Therapies Needed
Paul M. O'Byrne
The Journal of Clinical Pharmacology 39 ( 3) 230 -236
1
1999
The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise.
Paul M. O'Byrne , Graham L. Jones
The American review of respiratory disease 134 ( 1) 69 -72
103
1986